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Comparative materials differences revealed in
engineered bone as a function of cell-specific
differentiation
Eileen Gentleman1,2, Robin J. Swain1, Nicholas D. Evans1,2, Suwimon Boonrungsiman1,2, Gavin Jell1,2,
Michael D. Ball1,2, Tamaryn A. V. Shean3, Michelle L. Oyen3, Alexandra Porter1
and Molly M. Stevens1,2*
An important aim of regenerative medicine is to restore tissue function with implantable, laboratory-grown constructs that
contain tissue-specific cells that replicate the function of their counterparts in the healthy native tissue. It remains unclear,
however, whether cells used in bone regeneration applications produce a material that mimics the structural and compositional
complexity of native bone. By applying multivariate analysis techniques to micro-Raman spectra of mineralized nodules
formed in vitro, we reveal cell-source-dependent differences in interactions between multiple bone-like mineral environments.
Although osteoblasts and adult stem cells exhibited bone-specific biological activities and created a material with many of
the hallmarks of native bone, the ‘bone nodules’ formed from embryonic stem cells were an order of magnitude less stiff,
and lacked the distinctive nanolevel architecture and complex biomolecular and mineral composition noted in the native
tissue. Understanding the biological mechanisms of bone formation in vitro that contribute to cell-source-specific materials
differences may facilitate the development of clinically successful engineered bone.
Disease and injury so severe that the body cannot healnaturally necessitate clinical intervention to restore a levelof tissue function. One aim of regenerative medicine is
to meet this need with laboratory-grown constructs that can be
surgically implanted, as they may avoid many problems associated
with allogenic and autogenic grafts such as limited availability1,
immune compatibility2, and disease transmission3. Central to such
strategies is the re-establishment of tissue functionality by way
of tissue-specific cells contained within the constructs, be they
somatic, genetically reprogrammed or adult/embryo-derived stem
cells. Whether they contract synchronously in the case of cardiac
tissue, translate sound vibrations to electrical signals as in the
inner ear or produce load-bearing extracellular matrix (ECM) as in
connective tissues such as bone, the primary determinant of success
of a regenerative medicine therapy will invariably be dependent
on whether or not the cells replicate the functionality of their
counterparts in the healthy tissue.
It is particularly challenging to isolate and culture functional
tissue-specific cells in sufficient quantities to provide effective
therapies. Owing to their unlimited self-renewal capacity and
plasticity potential, embryonic stem cells (ESC; refs 4, 5) have
attracted widespread interest and have recently gained FDA
approval for human trials6. However, ethical and safety issues
remain because of their potential for tumour formation7. Stem cells
derived from adult tissues such as bonemarrow, which are currently
being investigated in over 700 clinical trials in the US (ref. 8),
avoid many issues that may preclude ESC use, but may lack their
unlimited proliferation potential. In addition, both embryonic and
adult stem cells may need to undergo directed differentiation before
use and the efficacy of available protocols remains controversial.
It is also often difficult to determine whether cells are functioning
1Department of Materials; 2Institute of Biomedical Engineering, Imperial College London, London SW7 2AZ, UK, 3Cambridge University Engineering
Department, Cambridge CB2 1PZ, UK. *e-mail: m.stevens@imperial.ac.uk.
as they would in the native tissue. Researchers use a combination
of molecular markers, gene expression and histological stains, but
many methods fail to assess global biochemical, mechanical and
structural properties that determine cell and tissue function.
Bone is a prime target for regenerative medicine therapies with
over two million replacement procedures carried out annually
worldwide9. Bone is also an ideal tissue for investigating cell
sources for regenerative medicine, as cells derived from bone, adult
stem cells and ESC have all been reported to form mineralized,
bone-like nodules in vitro10–13. Despite this, a detailed comparative
understanding of the biological activities, architecture, mechanical
properties and biochemical/material composition of these nodules
is still elusive. In the body, bone develops through a tightly regulated
process leading to a hierarchically ordered, three-dimensional
structure14. It is unclear how similar the mineralized material
formed from cells cultured in vitro is to native bone.
Here we formed mineralized nodules in vitro from mouse
ESC, neonatal calvarial osteoblasts (OB) and adult bone-marrow-
derived mesenchymal stem cells (MSC) and compared them
with one another and native bone using a combination of
materials and biological characterization methods. Our results
reveal clear differences in the bone-like material formed. They
also provide insight into the biological mechanisms that drive
these processes, and highlight the importance of cell source in
regenerative medicine.
To compare mineralized nodules formed by ESC, OB and
MSC, we grew them in osteogenic medium for 28 days. All three
cell types formed dense structures described in the literature as
‘bone nodules’10–12; however, the nodules appeared different on
visual inspection. ESC formed nodules quickly from highly con-
fluent multilayered regions that developed into dense mineralized
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Figure 1 | Mineralized nodules formed from three different cell sources analysed by standard microscopy techniques. Mineralized nodules formed from
ESC (a,d,g,j), OB (b,e,h,k) and MSC (c,f,i,l) after 28 days in culture. a–c, Phase contrast images of ESC nodules appear dark whereas those from OB and
MSC are bright. d–f, The calcium stain, ARS, is positive on nodules from all three cell sources. g–i, ARS stained nodules observed using epifluorescence
microscopy (excitation 510–560 nm, emission>590 nm) further confirm the presence of calcium-containing mineral in all cultures. (Scale bars in a–i
represent 200 µm.) j–l, SEM micrographs showing large dense nodule structures raised from the culture surface (scale bars in j–l represent 10 µm).
structures (Fig. 1a). In contrast, OB and MSC formed nodules
more slowly and in discrete patches, preceded by cellular aggre-
gation before mineralization (Fig. 1b,c). Despite these differences,
all nodules stained positive for Alizarin Red S (ARS), a histological
stain used to detect calcified tissue by its chelation with calcium
(Fig. 1d–f,g–i). Scanning electron microscopy (SEM) revealed that
the nodules were between 100 µm and 1.5mm in diameter and
raised from the culture surface by as much as 150 µm (Fig. 1j–l).
Using energy-dispersive X-ray (EDX) spectroscopy, we identified
Ca and P peaks in spectra of mineralized nodules from all three cell
sources (data not shown), with Ca:P ratios similar to those observed
in native bone15. However, we could not detect consistent differ-
ences between nodules using either of these techniques. Standard
biological techniques such as morphological and histological analy-
ses thereby supplied limited distinguishable information between
nodules, indicating a more systematic, materials-based analytical
approach was necessary.
Mineralization was not apparent during the first two weeks of
culture, so dense cellular/proteinaceous aggregates, which precede
nodule formation, were examined instead. Analyses were carried
out on live cell cultures using micro-Raman spectroscopy—a non-
destructive technique based on the inelastic scattering of light by
chemical bonds, which can be used to determine the biomolecular
composition of cells or tissues by the relative intensities of
characteristic molecular vibrations16.
Raman spectra of ESC before mineralization were dominated
by protein features and peaks indicative of nucleic acids and
phospholipids (Fig. 2a), suggesting that premineralized ESC nod-
ules consisted of cells combined with a proteinaceous matrix.
In contrast, spectra from premineralized OB and MSC revealed
weaker nucleic acid and phospholipid signatures, and were dom-
inated by different protein spectral features than ESC. The spec-
tral regions detected in OB and MSC were similar to those
observed in spectra of standards created from type-II collagen17,
2 NATURE MATERIALS | ADVANCE ONLINE PUBLICATION | www.nature.com/naturematerials
© 2009 Macmillan Publishers Limited.  All rights reserved. 
 
NATURE MATERIALS DOI: 10.1038/NMAT2505 ARTICLES
600 800 1,000 1,200 1,400 1,600
In
te
ns
ity
 (
ar
b.
 u
ni
ts
)
1,800
Type-ll
collagen
MSC
OB
ESC 71
7
78
6
8
53
8
15
92
1
93
6
1,0
0
3
1,
26
9
1,6
65
1,
24
6
1,6
59
1,
57
5
1,
30
1
1,
28
4
1,1
271,0
95
1,0
65
87
2 1
10R
el
at
iv
e 
ex
pr
es
si
on
100
1,000
10,000
ESC
OB
MBSC
Col2a1 Sox9
Raman shift (cm¬1)
a b
c d e
Figure 2 | Raman spectroscopy, immunostaining and gene expression evidence for type-II collagen in differentiating cultures. a, Raman spectra of
premineralization ESC, OB and MSC nodules plotted with the spectrum of type-II collagen standards. ESC spectra were marked by protein features
including the amide I band (1,659 cm−1), skeletal C–C vibrations (936 cm−1) and amide III vibrations (1,284 cm−1; ref. 41). Peaks indicative of nucleic acids
(786, 1,095, 1,575 cm−1) and bands corresponding to phospholipids (717, 1,065, 1,127, 1,301 cm−1; ref. 42) were also apparent. OB and MSC spectra had
weaker nucleic acid and phospholipid signatures, and different protein spectral features than ESC including C–C backbone stretch (815 cm−1), skeletal C–C
vibrations (936 cm−1), C–N–H amide III stretch (1,246 and 1,269 cm−1) and molecular vibrations in tyrosine (853 cm−1), hydroxyproline (872 cm−1) and
proline (921 cm−1; ref. 17). b, Mean relative expression (and s.d.) compared with the expression of ESC at the same time point determined by quantitative
real-time reverse-transcriptase polymerase chain reaction (RT-PCR) of genes Col2a1 (type-II collagen) and Sox9 (a transcription factor necessary for
cartilage formation) in premineralization cultures of ESC, OB and MSC. Note that the y axis is a logarithmic scale. (n≥ 3.) c–e, Immunostaining for type-II
collagen in cultures of ESC (c), OB (d) and MSC (e) after 14 days in culture. The scale bar in c, d and e is 200 µm.
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Figure 3 | Raman spectra of mineralized nodules and native bone, and their properties as determined by univariate peak analysis. a, Raman spectra of
native mouse bone, ESC, OB and MSC after 28 days in culture. Notice that the Raman spectra of mineralized nodules are similar to one another and to
native bone. The PO3−4 ν1 symmetric stretch near 960 cm−1 dominates the spectra of all four materials. Peaks associated with the substituted CO
2−
3 ν1
in-plane vibrations near 1,070 cm−1 are also evident. Lower-intensity vibrations corresponding to the ν2, ν3 (1,020–1,100 cm−1) and ν4 phosphate modes
are apparent. Prominent protein bands, such as the amide I mode (1,595–1,720 cm−1) and amide III envelope (1,243–1,269 cm−1) are also visible. Spectra
are scaled to represent equal PO3−4 ν1 peak intensity. ESC matrix peaks between 1,200 and 1,720 cm−1 seem stronger than those of the other materials
because ESC had the lowest mineral to matrix ratio. b, Table detailing the phosphate peak (PO4−3 ν1) parameters and mineral properties as determined by
univariate peak analysis carried out by curve fitting Raman spectra of day-28 mineralized nodules. n represents the number of spectra recorded for each
group. A Kruskal–Wallis ANOVA was used to determine statistical significance (p<0.05) combined with a Mann–Whitney test with Bonferroni correction
to determine statistical significance between individual groups. Statistically significant difference between Sample X and *native bone, † ESC, ‡ OB
and § MSC.
the main protein constituent of cartilage and a precursor for
bone mineralization in the embryonic skeleton. Analysis of the
spectral covariance matrix18 revealed correlation coefficients of
0.96 for both OB and MSC when compared with type-II collagen
standards (computed over the 415–1,600 cm−1 spectral range).
These characteristic peaks were not observed in ESC spectra, and
correlation coefficients suggested they were less similar to type-II
collagen standards (R= 0.85).
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Figure 4 | Factor analyses of mature mineralized nodules after 28 days in culture. a–c, Matrix factors describing the proteinaceous component of
mineralized nodules for ESC, OB and MSC. e–g,i–m, Mineral factors generated for ESC (e,i), OB (f,j,l) and MSC (g,k,m). The peak positions and full-widths
at half-maximum (FWHM) for the PO3−4 ν1 and CO
2−
3 ν1 peaks are noted. d,h, Raman spectra of type-I collagen (d) and synthetic cHA (h) for comparison.
Note the similarities between the matrix factors (a,b,c) and type-I collagen, which contains peaks corresponding to the C–C backbone stretch at 815 cm−1,
proline and hydroxyproline bands at 853, 872 and 921 cm−1, and amide I near 1,665 cm−1. Spectra of cHA standards show similarities to the
carbonate-substituted apatite mineral factors in mineralized nodules (e–g), with the exception that the PO3−4 ν1 band in cHA is shifted to a higher
wavenumber and has a lower FWHM, indicating that it is more crystalline.
To further confirm the presence of type-II collagen in
premineralized OB and MSC cultures and its absence in ESC, we
immunostained day 14 cultures with antibodies to type-II collagen.
Although OB and MSC showed clear staining in cell-protein
aggregates (Fig. 2d,e), we found no indication of type-II collagen
in ESC (Fig. 2c). Real-time RT-PCR, a technique used to quantify
the expression of genes indicative of a particular cell phenotype,
confirmed this result. Although expression of Col2a1, the gene
for type-II collagen, increased by a factor of 3.45 ± 0.33, and
Sox9 (a gene essential for cartilage formation19) by a factor of
4.73±0.37 in ESC between plating and premineralization, OB and
MSC expressed 63 and 501 times more Col2a1 and 219 and 829
times more Sox9, respectively, compared with ESC (Fig. 2b). These
differences suggest that a type-II collagen intermediary precedes
mineralized nodule formation inOB andMSCbut not in ESC.
By day 28, ESC, OB and MSC cultures all contained mineralized
nodules, and we did not detect Raman spectral peaks indicative
of type-II collagen. Indeed as cultures mineralized, expression of
Col2a1 decreased in OB and MSC (see Supplementary Fig. S1).
Raman spectra of mature mineralized nodules instead revealed
bands characteristic of native bone (Fig. 3a), with correlation
coefficients ≥ 0.99 (mineralized nodules compared with native
bone). Spectra of both native bone and mineralized nodules were
dominated by the PO3−4 ν1 symmetric stretch near 960 cm
−1 and
weaker peaks associated with the substituted CO2−3 ν1 in-plane
vibrations near 1,070 cm−1 (ref. 20). These peaks correspond to
the mineral component of bone, hydroxyapatite Ca10(PO4)6(OH)2,
into which carbonate CO2−3 can substitute for the OH
− and/or
PO3−4 groups. In vivo, bone mineral is deposited on an ECM
composed predominately of type-I collagen. Raman spectra of
mineralized nodules and native bone reflected their proteinaceous
component and were marked by prominent protein bands
corresponding to the amide I mode (1,595–1,720 cm−1) and amide
III envelope (1,243–1,269 cm−1).
Such simple analyses, however, ignore the complexity of
interactions between multiple mineral environments present
in native bone. Therefore, we also applied the multivariate
technique, factor analysis, to Raman spectra of day-28 mineralized
nodules. Factor analysis can be used to interpret the results of
principal-component analysis, a multivariate technique used to
4 NATURE MATERIALS | ADVANCE ONLINE PUBLICATION | www.nature.com/naturematerials
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analyse large, complex data sets. Principal-component analysis
generates ‘principal components’, which contain spectral features
corresponding to the molecular species responsible for statistical
variation between spectra. When applied to spectra of mineralized
nodules, the principal components can be ‘rotated’ (linearly
combined) to give ‘factors’ that describe the mineral and matrix
environments in a sample21. The position and shape of the
PO3−4 ν1 band in factors is especially important, as it can reveal
changes in ionic substitution and mineral crystallinity. Native bone
contains three distinct mineral environments: B-type carbonate-
substituted apatite, with a PO3−4 ν1 peak between 955 and 959 cm
−1,
crystalline non-substituted hydroxyapatite, with a peak between
962 and 964 cm−1, and an amorphous phosphate species, with
a peak between 945 and 950 cm−1 (ref. 21), which together
contribute to bone’s function.
Factor analysis of OB and MSC spectra each produced three
mineral factors. The two dominant OB mineral factors describe
a carbonate-substituted apatite (Fig. 4f) and a non-substituted,
crystalline apatite (Fig. 4j). The third, minor OB mineral factor
(Fig. 4l) indicates an amorphous phosphate species. Factor analysis
of MSC nodules similarly yielded a carbonate-substituted apatite
(Fig. 4g) and a non-substituted crystalline apatite (Fig. 4k) as the
main mineral species. A less prominent amorphous phosphate
species (Fig. 4m) was also present. In contrast, factor analysis of
ESC spectra generated only two mineral factors: a primary mineral
factor describing a lightly carbonated crystalline apatite (Fig. 4e),
and a secondary, minor factor describing a more carbonated,
less crystalline apatite (Fig. 4i). Raman spectra of synthetic
carbonated hydroxyapatite (cHA) standards (Fig. 4h) showed
marked similarities to the carbonate-substituted apatite mineral
factor detected in spectra from all three cell types (Fig. 4e–g).
These data suggest that OB and MSC nodules contain mineral
environments that are similar to those observed in native bone,
namely a combination of carbonate-substituted and crystalline
non-substituted apatite, and amorphous phosphate species. In
contrast, ESC nodules were dominated by a single mineral factor,
which was similar to synthetic cHA, and failed to show the more
complex interaction ofmineral species observed inOB andMSC.
Typical measures used to assess bone quality as determined
by univariate peak-area analysis also confirmed that the mineral
in ESC nodules was different from that in OB, MSC and native
bone. The mineral-to-matrix ratio, a measure of the PO3−4 ν1 peak
area to that of the spectral region indicative of protein molecular
vibrations (1,600–1,720 cm−1), was significantly lower in ESC than
OB, MSC or native bone (p< 0.05) (Fig. 3b). We also found that
the carbonate-to-phosphate ratio, which measures substitution of
carbonate into the apatite lattice, was significantly higher in ESC
than in OB, MSC or native bone. Similarly, the degree of mineral
crystallinity, calculated from the FWHM of the PO3−4 ν1 band,
was significantly higher in ESC than in the other materials (lower
FWHM). Taken together, these data suggest that, although ESC
formed less mineral than OB and MSC, this mineral was more
crystalline and had a higher degree of carbonate substitution.
ESC nodules differed from OB and MSC not only in their min-
eral, but also in their organic phase. Factor analysis distinguished
matrix factors for ESC, OB and MSC nodules (Fig. 4a–c) that
reflected their proteinaceous component, and all showed sim-
ilarities to spectra of type-I collagen standards (Fig. 4d). Gene
expression analyses, however, noted clear differences among the
different cell types. Col1a1, the gene for type-I collagen, was
expressed at a level two orders of magnitude lower in mature
cultures of ESC comparedwithOB andMSC (Fig. 5d), andwhenwe
re-examined premineralization cultures, we found that ESC seemed
not to differentiate to osteoblasts in great numbers at all. Day-14
ESC cultures did not stain positively for the transcription factor
Runx2 (Fig. 5a), an essentialmolecular switch for bone formation22,
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Figure 5 | Immunostaining, gene expression and alkaline-phosphatase
(ALP) evidence of osteoblastic differentiation. a–c, Fluorescence
micrographs showing immunostaining against transcriptional factor Runx2,
an early marker for osteoblastic differentiation, in ESC, OB and MSC,
respectively, after 14 days in culture. Notice that bright staining is localized
to cell nuclei in OB and MSC whereas only diffuse stain is evident in ESC.
The scale bar in a, b and c is 200 µm. d, Mean relative expression (and s.d.)
as determined by quantitative RT-PCR of osteogenic genes Bglap
(osteocalcin) and Col1a1 (type-I collagen) in mature mineralized cultures,
and Runx2 in premineralization cultures of ESC, OB and MSC (n≥ 3). e, ALP
activity (mean activity±s.d.) as measured by the production of
p-nitrophenyl per minute per 106 cells in cultures of ESC, OB and MSC over
28 days in culture.
whereas OB andMSC did (Fig. 5b,c). Real-time RT-PCR confirmed
that Runx2 expression in premineralized OB and MSC was 109
and 199 (respectively) times higher than that observed in ESC
(Fig. 5d). The bone-specific protein osteocalcin, a late marker of
osteoblast differentiation, similarly indicated limited osteoblastic
differentiation in ESC.Bglap, the gene for osteocalcin, was expressed
at levels 1,035 and 17 times higher in mature cultures of OB and
MSC, respectively (Fig. 5d), compared with ESC.
To better understand mineral formation within nodules, we
also carried out ultrastructural analysis. Bright-field transmission
electron microscopy (TEM) revealed nodules to be multilayered
structures containing cells and a partially mineralized ECM
(Fig. 6a,b and Supplementary Fig. S2). Selected-area electron
diffraction confirmed mineralized regions in both ESC and OB
to be crystalline hydroxyapatite (Fig. 6a,b, insets)23. The ECM of
OB nodules was composed of banded fibrils (Fig. 6e) with average
diameters of 64.6± 9.8 nm and a periodicity of 60.2± 1.2 nm,
which is similar to reported values for mammalian collagen24.
Mineral formation in OB nodules also seemed to be mediated by
calcium- and phosphate-containing (confirmed by EDX) matrix
NATURE MATERIALS | ADVANCE ONLINE PUBLICATION | www.nature.com/naturematerials 5
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Figure 6 | TEM micrographs of mineralized nodules formed after 28 days in culture. a, Cross-section through an ESC nodule. A layer of cells is visible
across the top of the nodule as indicated by C. The middle layer is composed of extracellular matrix (ECM). A dense layer of mineral (M) is also visible. The
inset shows the selected-area electron diffraction pattern of the dense mineral portion of the nodule and is indicative of hydroxyapatite. b, Micrograph of a
cross-section through an OB nodule. Cells are indicated by C and dense mineral by M. Fibrous ECM is also apparent. Selected-area electron diffraction of
dense areas (inset) is indicative of hydroxyapatite. The scale bar in a and b is 4 µm. c, Higher-magnification image of fibrous protein (FP) between cells (C)
in an ESC nodule. Note that the protein lacks the characteristic banding present in mammalian collagen. Scale bar=0.5 µm. d, Micrograph showing
unmineralized (black arrow) and mineralized banded fibrous proteins (white arrows) in OB nodules. e, Higher-magnification TEM micrograph of the ECM
of OB nodules showing banding of fibrous proteins typical of mammalian collagen. f, Micrograph of matrix vesicle (MV) containing needle-like apatite
crystals inside a cell (C) within an OB nodule. A bursting matrix vesicle (BV) is also visible. The scale bar in d, e and f is 0.2 µm.
vesicles created intracellularly, which were observed bursting
into the extracellular space, releasing their apatite crystallites
(Fig. 6f). Although they lacked the collagen–mineral organization
of native bone, these mineral crystallites were observed to
associate with collagen fibrils (Fig. 6d). Conversely, the ECM
of ESC nodules was dominated by fibrous structures with a
diameter of 39.6±4.6 nm (Fig. 6c). These fibrils rarely showed the
characteristic banding pattern of collagen, and mineral formation
was only occasionally observed to take place in intracellularly
formed, apatite-containing vesicles. Furthermore, we failed to
detect apatite crystallites associated with protein fibrils in ESC
nodules; it instead formed in discrete clusters. Indeed, when we
examined their mechanical behaviour by nanoindentation, we
found that ESC nodules were significantly (p < 0.001) less stiff
than those formed from OB or MSC (0.11± 0.07 µNnm−1 ESC;
7.3 ± 4.3 µNnm−1 OB; 3.0 ± 3.7 µNnm−1 MSC; Supplementary
Fig. S3), suggesting that the lack of connectivity between themineral
and fibrous proteins of the ESC nodules significantly impacted their
mechanical properties.
Taken together, these results suggest that a mechanism other
than osteoblast-mediated mineralization of collagen fibrils was in
large part responsible for the ‘bone nodules’ observed in ESC, and
therefore the mineral may have been, at least in part, dystrophic25.
Dystrophic mineral has been previously described26 and can form
when inorganic phosphates from locally high levels of ALP activity
precipitate with calcium ions in cell culture media. ALP activity
per cell was high in proliferating cultures at early time points and
decreased as cultures mineralized, as has been previously reported27
(Fig. 5e). ALP activity in ESCwas similar to that observed inOB and
MSC. However, as differentiating ESC expressed osteoblastic genes
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at levels nearly two orders of magnitude lower than OB and MSC,
this result suggests that non-osteoblastic cells in the ESC population
also produce ALP, facilitating deposition of dystrophic mineral.
Indeed, we suggest that it is likely that much of the ARS staining of
ESC nodules in this and other studies stems from this and not solely
through the activity of mineralizing osteoblasts.
We have shown that OB and MSC form a type-II collagen
intermediary before mineralization. This transition resembles
endochondral ossification, the process by which long bones in the
embryonic skeleton develop by first forming a cartilage template.
Although an analogous process in vitro may seem unlikely, as
embryonic bone development is strictly delineated depending on
skeletal location, there is evidence to suggest that bone progenitors
are actually fairly plastic28. As such, calvarial osteoblasts that would
normally form bone by intramembranous ossification (the process
by which flat bones in the skull form by depositing mineral directly
on a collagenous ECM) may be able to take a different differenti-
ation pathway. For example, the application of mechanical forces
is known to favour endochondral versus intramembranous ossifi-
cation, regardless of how the bone would normally form29. Minor
changes in the presence of growth factors during development also
have an influence. Transgenic mice that express fibroblast growth
factor 9 in the cranial mesenchyme, for example, form cranial bone
by endochondral rather than intramembranous ossification30.
The type-II collagen detected in OB andMSC cultures, however,
did not persist. The cells instead expressed osteogenic genes and
created a proteinaceous ECM that mineralized over time, as has
been noted in native bone. Differentiating ESC, conversely, failed
to express osteogenic genes at levels noted in OB and MSC,
and the mineral in ESC nodules failed to closely associate with
matrix proteins. The poor composite structure in ESC nodules
also impacted their mechanical properties, as nanoindentation
determined they were significantly less stiff than OB and MSC
nodules. These results suggest that standard protocols widely
reported to direct the differentiation of ESC to osteoblasts that
form a bone-like material fail to do so in significant numbers
and/or fail to prevent non-osteoblastic differentiation. This may
significantly impact the outcome of bone regenerative therapies,
regardless of how long the cells persist after implantation. In in vivo
models, osteogenic scaffolds seeded with dermal fibroblasts yielded
similar results to no-cell controls (that is, lack of tissue formation)31,
suggesting that osteogenic cells are an essential component of
bone regeneration constructs. Moreover, although the need for
differentiation in vitro before implantation is controversial, some
convincing reports demonstrate improved tissue outcomes when
cells are cultured in the presence of tissue-stimulating factors
before implantation, even in so-called niches, where factors that
presumably stimulate appropriate differentiation are present32.
OB and MSC nodules contained three distinct mineral envi-
ronments, which in native bone are thought to indicate continued
remodelling and reflect a combination of older and newer bone
in small bone-forming units called osteons33. Multiple mineral
environments in native bone are also reflected in its carbonate-to-
phosphate ratio and crystallinity, as both increase with increasing
tissue age34. ESC nodules lacked complex combinations of multi-
ple mineral environments, were significantly more crystalline and
had a significantly higher carbonate-to-phosphate ratio than those
formed from OB and MSC. This suggests that mineral in ESC
nodules more closely resembled the crystalline, highly carbonated
mineral in older bone than that in normal bone. Not surprisingly,
changes in mineral have been shown to affect bone’s mechanical
properties. Akkus et al. among others have correlated increasing
carbonate substitutions and crystallinity with increasing age and
deteriorating mechanical properties35,36. Similarly, spectroscopic
studies of osteoporotic bone reveal a narrower range in parameters
such as crystallinity and carbonate-to-phosphate ratio compared
with normal bone, suggesting that the combination of multiple
mineral environments contributes to mechanical function37. Given
the well-documented effects associated with minor changes in
bone-mineral environments, our results highlight the importance
of precisely matching the biochemical and material characteristics
of engineered bone to those of the native tissue.
A fundamental hurdle in taking regenerative medicine from the
laboratory to the clinic is determining whether cells cultured in vitro
truly mimic their counterparts in the healthy native tissue. Here
we detail the processes by which cells from three sources form
bone-like material in vitro and highlight the differences between
them. OB and MSC were successfully able to create a material
with many hallmarks of native bone, whereas that formed by ESC
differed in its composition, stiffness, nanolevel architecture and
development. Only by assessing the material with both biological
and materials-based techniques could these differences, which will
probably have a significant impact on clinical success, be discerned.
Methods
Cell culture. ESC, OB and MSC were routinely cultured and differentiated in
medium containing ascorbic acid, β-glycerophosphate and dexamethasone as
described in the Supplementary Methods.
Raman standards. Type-I collagen from bovine tendon and type-II collagen from
chicken sternal cartilage were purchased from Sigma. Fresh calvarial mouse bone
samples were obtained from adult mice; spectral measurements were made within
two hours. cHAwas prepared by a precipitation route38.
Alizarin Red S staining. Day-28 cultures were rinsed with PBS, fixed for 20min in
formalin, rinsed, stained for 10min in 2% (w/v) ARS in deionizedH2O, rinsed again
and air dried39. Stained plates were viewed using phase contrast and epifluorescence
microscopy (excitation 510–560 nm, emission>590 nm).
Scanning electron microscopy and energy-dispersive X-ray spectroscopy.
Day-28 nodules were fixed, dried and gold or carbon coated and viewed using a
Leo 1525 Gemini scanning electron microscope with an EDX detector as described
in Supplementary Methods.
Micro-Raman spectroscopy. Raman spectra were collected from live cell cultures
maintained in DMEM with 1× penicillin/streptomycin at 37 ◦C. Spectra were
measured with a Renishaw InVia spectrometer connected to a Leica microscope
and equipped with a 785 nm line-focus laser (120mW before objective) with an
elliptical beam profile. Refer to Supplementary Methods for a detailed description
of spectra collection and spectral analysis.
Immunocytochemistry. After 14 days, some cultures were rinsed with PBS, fixed
in a solution of 4% (w/v) paraformaldehyde (Sigma) in deionized H20 for 20min
and stained with antibodies to type-II collagen (R&D Systems; 1:40) or Runx2
(Santa Cruz Biotechnology; 1:80). Primary antibodies were detected with secondary
antibodies conjugated to FITC and viewed using epifluorescencemicroscopy.
Quantitative real-time RT-PCR. Cells were detached from culture plates at the
indicated time points and snap frozen. RNA was extracted, reverse transcribed
and amplified as described in the Supplementary Methods. Sequences and cycling
conditions for primers to Gapdh, Bglap, Runx2, Sox9, Col1a1 and Col1a2 are given
in Supplementary Table S1. Relative expression was calculated using the Pfaffel
method40. As the onset of mineralization was somewhat variable, expression levels
combine data from at least three time points in the appropriate range. Data are
presented as the mean relative expression ±standard deviation compared with the
expression of ESC at the same time point.
Transmission electron microscopy and selected area electron diffraction.
Day-28 nodules were prepared for TEM through either a standard protocol for
analysis of cell structure or an anhydrous procedure for examination of mineral
structure and chemistry. 70 nm sections were viewed on a Jeol 2000 as described in
Supplementary Methods.
Nanoindentation mechanical testing. Stiffness of day-28 nodules was assessed
by displacement-controlled nanoindentation on a Hysitron UBI nanoindentor as
described in Supplementary Methods.
Alkaline-phosphatase activity. ESC, OB and MSC cultures were lysed by three
freeze–thaw cycles in dH2O. ALP activity was assessed using p-nitrophenyl
phosphate as a substrate (Sigma); the absorbance of its product, p-nitrophenyl,
was measured at 405 nm. ALP activity was normalized to cell number, which
was quantified by measuring the activity of the stable cytosolic enzyme lactate
dehydrogenase with a CytoTox96 assay (Promega).
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